OrbusNeich Sponsors and Participates in World Heart Day 2023 Events Promoting Message of “Strengthening Heart Health”

(Hong Kong, 24 October 2023) – OrbusNeich Medical Group Holdings Limited (“OrbusNeich” or the “Group”; stock code: 6929), a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures, sponsored the World Heart Day 2023 events jointly organized by the Hong Kong College of Cardiology and the World Heart Federation, and supported the World Heart Day 2023 Carnival cum Run for Heart run held at the Hong Kong Science Park yesterday. A total of 14 OrbusNeich employees participated in the run, aiming to enhance public awareness of heart health and healthy lifestyles.

Mr. David Chien, Chairman, Executive Director and Chief Executive Officer of OrbusNeich, said, “We are pleased to be part of this meaningful activity to promote to the public the concept of heart protection and strengthening the heart health. As a provider of solutions for treatment of vascular diseases, we believe it is important not only to save the lives of patients through innovative technologies, but also to raise public awareness and encourage people to be mindful of their heart health condition, therefore, to build a healthier future by improving their lifestyle. Looking ahead, we will continue to support and promote public health education in various ways.”

Photo 1: OrbusNeich sponsors and participates in the World Heart Day 2023 Carnival cum Run for Heart events.

Photo 2: Mr. Jason Chen, Executive Director and Chief Financial Officer of OrbusNeich, presents a cheque on behalf of the Group to the Hong Kong College of Cardiology, the event organizer.

— End —

About OrbusNeich Medical Group Holdings Limited
OrbusNeich is a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. Headquartered in Hong Kong, China, OrbusNeich sells its products in more than 70 countries and regions worldwide. It also specializes in coronary stent products and is actively expanding into neuro vascular intervention and structural heart disease. As of 30 June 2023, OrbusNeich has more than 210 granted patents and published patent applications worldwide. Its in-house R&D team has more than two decades of product development experience and has developed world-leading proprietary technologies.

For more information, please visit the Group’s official website: https://orbusneich.com/

About World Heart Day 2023
The World Heart Federation held the inaugural World Heart Day in 2000, with more than 100 countries now participating in the event every year. The Hong Kong College of Cardiology is committed to raising the standard of cardiac medical care and improving the heart health of Hong Kong citizens. Each year, World Heart Day is marked by a series of public events. This year’s theme is “Running for Strong Hearts GO (跑步強心齊齊Go)”, and includes such activities as the World Heart Day 2023 Carnival cum Run for Heart held at the Hong Kong Science Park on 23 October, the Hong Kong Heart Foundation drawing competition, and a series of online and offline health talks, to help Hong Kong people protect and improve their heart health.

For more details, please visit the official event website: https://worldheartday.org.hk/